TreatMajorDepressiveDisorderwithKetamineIVfrom SoftRebootWellnessSanFrancisco
Ketamineisananesthetictraditionallyusedfor painmanagement,butrecently,researchhas shownthatitmaybebeneficialintreatingmajor depressivedisorder.
SoftRebootWellness
offersketamineinfusion therapytopatientswith treatment-resistant depression.
Theclinicadministers low-doseketamine onceaweekforfourto sixweeks,depending onyoursymptomsand howwellyourespond tothetreatment.
Ketamineinfusions reportedly“reboot”the synapsesorsignalsinthe brain,offeringadifferent approachtotreatingor managingtreatmentresistantdepression.
Theseinfusionsincreasethe productionofproteinslike Brain-DerivedNeurotrophic Factors(BDNF)andreverse synapsedamage,leadingto betteremotionalregulation.
Theclinicprescribes pairingketamine infusionswithcognitive behavioraltherapyto extendits
antidepressanteffect.
